ALA-RDT in GBM: protocol of the phase I/II dose escalation trial of radiodynamic therapy with 5-Aminolevulinic acid in patients with recurrent glioblastoma

Despite improvements in surgical as well as adjuvant therapies over the last decades, the prognosis for patients with glioblastoma remains poor. Five-Aminolevulinic acid (5-ALA) induced porphyrins are already ...

Source: Radiation Oncology - January 22, 2024 Category: Cancer & Oncology Authors: Niklas Benedikt Pepper, Hans Theodor Eich, Michael M üther, Michael Oertel, Stephan Rehn, Dorothee Cäcilia Spille and Walter Stummer Tags: Study Protocol Source Type: research